{"id":"W3121037727","doi":"10.1016/j.obmed.2020.100312","title":"Friend or foe? ACE2 inhibitors and GLP-1R agonists in COVID-19 treatment","year":2021,"lang":"en","type":"review","venue":"Obesity Medicine","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto; Toronto General Hospital; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Diabetes mellitus; Coronavirus disease 2019 (COVID-19); Obesity; Pandemic; Type 2 diabetes; Angiotensin-converting enzyme 2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Internal medicine; Coronavirus; Viral replication; Virus; Drug; Pharmacology; Disease; Virology; Endocrinology; Infectious disease (medical specialty)","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001793065,0.0008839093,0.006126241,0.0006335379,0.0002512249,0.00004067133,0.0002496711,0.0005958125,0.001035952],"category_scores_gemma":[0.07744202,0.0005109293,0.0004759578,0.001260499,0.001232281,0.00006661267,0.00055092,0.001094042,0.0000617667],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002876865,"about_ca_system_score_gemma":0.006597926,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002024156,"about_ca_topic_score_gemma":0.001321131,"domain_scores_codex":[0.9945362,0.0006146769,0.001510974,0.001395136,0.001118373,0.000824618],"domain_scores_gemma":[0.9837016,0.01307469,0.0003726874,0.001055911,0.0001881577,0.00160689],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002167892,0.0009352979,0.001357308,0.06843778,0.0007693241,0.007880351,0.001054539,3.110319e-7,0.00000153795,0.00007107285,0.008091104,0.9111846],"study_design_scores_gemma":[0.004714771,0.002016656,0.0002091137,0.04343869,0.001840814,0.00009988274,0.000222395,0.000004489576,0.000001491492,0.00003227725,0.9470567,0.0003627727],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002222621,0.9835201,0.00002725481,0.01252365,0.0003728896,0.002812165,0.00005552328,0.00008590452,0.0003802551],"genre_scores_gemma":[0.0001867831,0.9905973,0.0001066612,0.00166036,0.001185458,0.0003357279,0.000306883,0.0000739721,0.005546871],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9389656,"threshold_uncertainty_score":0.9998772,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1875340442136032,"score_gpt":0.5259942405753399,"score_spread":0.3384601963617367,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}